iSyn: WebGL-Based Interactive De Novo Drug Design

We present iSyn, a WebGL-based tool for interactivede novo drug design. It features an evolutionary algorithm that automatically designs novel ligands with drug-like properties and synthetic feasibility using click chemistry. Isyn interfaces with our popular and fast molecular docking engine idock, remarkably reducing the evaluation and ranking time of drug candidates. Furthermore, inspired by our user friendly and high-performance WebGL visualizer iview, our iSyn also implements a tailor-made interactive visualizer to aid novel drug design. We believe iSyn can supplement the efforts of medicinal chemists in drug discovery research. To illustrate the utility of iSyn in generating novelligands ex nihilo, we designed predicted inhibitors of two important drug targets, which are RNA editing ligase 1(REL1) from T. Brucei, the etiological agent of African sleeping sickness, and cyclin-dependent kinase 2 (CDK2), a positive regulator of eukaryotic cell cycle progression. Results show that iSyn managed to significantly enhance the predicted binding affinity of the best generated ligand by more than 3 orders of magnitude in potency. Isyn is written in C++, Python, HTML5 and JavaScript. It is free and open source, available athttp://istar.cse.cuhk.edu.hk/iSyn.tgz. It has been tested successfully on both Linux and Windows.

[1]  J Andrew McCammon,et al.  AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design. , 2013, Journal of molecular graphics & modelling.

[2]  Yang Zhang,et al.  Generating Triangulated Macromolecular Surfaces by Euclidean Distance Transform , 2009, PloS one.

[3]  Kwong-Sak Leung,et al.  istar: A Web Platform for Large-Scale Protein-Ligand Docking , 2014, PloS one.

[4]  Rommie E. Amaro,et al.  AutoGrow: A Novel Algorithm for Protein Inhibitor Design , 2009, Chemical biology & drug design.

[5]  Gisbert Schneider,et al.  Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.

[6]  Kwong-Sak Leung,et al.  iview: an interactive WebGL visualizer for protein-ligand complex , 2014, BMC Bioinformatics.

[7]  Reza Salavati,et al.  An RNA Ligase Essential for RNA Editing and Survival of the Bloodstream Form of Trypanosoma brucei , 2001, Science.

[8]  Kwong-Sak Leung,et al.  idock: A multithreaded virtual screening tool for flexible ligand docking , 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB).

[9]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[10]  J Andrew McCammon,et al.  LigMerge: A Fast Algorithm to Generate Models of Novel Potential Ligands from Sets of Known Binders , 2012, Chemical biology & drug design.

[11]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[12]  Kwong-Sak Leung,et al.  Interactive Drug Design in Virtual Reality , 2011, 2011 15th International Conference on Information Visualisation.

[13]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[14]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[15]  Jacob D. Durrant,et al.  AutoClickChem: Click Chemistry in Silico , 2012, PLoS Comput. Biol..

[16]  Ryan G. Coleman,et al.  ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..

[17]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[18]  Peter Kulchyski.  and , 2015 .

[19]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[20]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.